Some even split doses into tiny injections multiple times per week
Targeting Erbin-mitochondria axis in platelets/megakaryocytes promotes B cell-mediated antitumor immunity
Hudson & Tabet 2003 Cochrane Review: A Cochrane Review of 15 clinical trials (including 13 of those in the meta-analysis above) assessed 1 to 3 g/day ALCAR supplementation versus placebo over 12 to 52 weeks in participants with mild to moderate dementia or cognitive decline
Do Not Use Semaglutide If You: Have a personal or family history of medullary thyroid carcinoma (MTC) Have Multiple Endocrine Neoplasia syndrome type 2 (MEN-2) Are pregnant, planning to become pregnant, or breastfeeding Have a history of pancreatitis or unexplained, persistent abdominal pain Have severe gastrointestinal disease (including gastroparesis) Have had an allergic reaction to semaglutide or any of its components Use With Caution If You Have: Gallbladder disease or a history of gallstones Kidney or liver impairment Diabetic retinopathy High triglyceride levels Frequent gastrointestinal issues such as reflux, nausea, or vomiting A history of alcohol use disorder Possible Side Effects May Include: Mild to moderate nausea, vomiting, diarrhea, or constipation Bloating or decreased appetite Fatigue or dizziness In rare cases, pancreatitis (inflammation of the pancreas) symptoms may include severe, persistent abdominal pain radiating to the back, sometimes with nausea or vomiting
